Terns Pharmaceuticals - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeTerns Pharmaceuticals
Terns Pharmaceuticals logo

Terns Pharmaceuticals

0 followers

TERN

Performance

About Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing a portfolio of small-molecule therapeutics to address serious diseases, with an emphasis on oncology and metabolic conditions such as obesity. The company conducts its research and development activities to advance drug candidates through clinical trials with the aim of delivering targeted cancer therapies and metabolic disease treatments. While the site highlights its headquarters and leadership, it emphasizes a global outlook in oncology and metabolic programs.

Recent News

No recent news for this company.

Recent Deals

Key Team Members

Andrew Gengos

Chief Financial Officer and Head of Corporate Development

Amy Burroughs

Chief Executive Officer

Melita Sun Jung

Chief Business Officer

Emil Kuriakose, MD

Chief Medical Officer

Scott Harris

Chief Development Officer

Key Facts

HQ Location

Foster City, United States

Founded

2017

Employees

51 - 200

Status

Public

Website

https://ternspharma.com